HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic
Market Cap
$801.40 Million
CN¥5.88 Billion CNY
Market Cap Rank
#14988 Global
#3985 in China
Share Price
CN¥10.14
Change (1 day)
+0.00%
52-Week Range
CN¥7.05 - CN¥17.72
All Time High
CN¥17.72
About

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more

HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.063x

Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million) by net assets (CN¥2.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2024)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.88 Billion CN¥115.44 Million 0.040x -66.89%
2023-12-31 CN¥2.75 Billion CN¥332.99 Million 0.121x -3.02%
2022-12-31 CN¥2.46 Billion CN¥307.33 Million 0.125x +217.79%
2021-12-31 CN¥2.20 Billion CN¥-233.00 Million -0.106x -2188.91%
2020-12-31 CN¥1.99 Billion CN¥-9.22 Million -0.005x +97.92%
2019-12-31 CN¥1.85 Billion CN¥-411.60 Million -0.223x -196.07%
2018-12-31 CN¥1.58 Billion CN¥366.45 Million 0.232x +168.84%
2017-12-31 CN¥1.61 Billion CN¥139.07 Million 0.086x +208.97%
2016-12-31 CN¥1.65 Billion CN¥46.01 Million 0.028x -88.10%
2015-12-31 CN¥1.42 Billion CN¥333.99 Million 0.235x +28.70%
2014-12-31 CN¥2.15 Billion CN¥392.58 Million 0.182x +360.00%
2013-12-31 CN¥2.26 Billion CN¥-158.31 Million -0.070x -172.98%
2012-12-31 CN¥2.31 Billion CN¥221.57 Million 0.096x +271.75%
2011-12-31 CN¥1.94 Billion CN¥-108.30 Million -0.056x -159.69%
2010-12-31 CN¥1.74 Billion CN¥162.99 Million 0.094x -65.32%
2009-12-31 CN¥1.66 Billion CN¥447.82 Million 0.270x +776.00%
2008-12-31 CN¥1.65 Billion CN¥-65.93 Million -0.040x -129.42%
2007-12-31 CN¥1.41 Billion CN¥191.10 Million 0.136x -22.95%
2006-12-31 CN¥1.08 Billion CN¥191.13 Million 0.176x -49.94%
2005-12-31 CN¥888.23 Million CN¥313.04 Million 0.352x +504.14%
2004-12-31 CN¥1.04 Billion CN¥60.69 Million 0.058x -54.38%
2003-12-31 CN¥560.39 Million CN¥71.65 Million 0.128x -47.23%
2002-12-31 CN¥526.17 Million CN¥127.49 Million 0.242x +720.86%
2001-12-31 CN¥501.11 Million CN¥14.79 Million 0.030x -77.75%
2000-12-31 CN¥466.36 Million CN¥61.85 Million 0.133x -3.81%
1999-12-31 CN¥422.13 Million CN¥58.21 Million 0.138x +44.85%
1998-12-31 CN¥430.69 Million CN¥41.00 Million 0.095x --